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Conclusion: There is a clear-cut increment in life threatening ventricular tachyarrhyth- 
mia incidence in ICD patients in weeks after 9/l 1 with a return to baseline after approxi- 
mately 30 days. 
(n=50, 19% of total), a cause of SCD remained uncertain in only 36% (~~0.05 vs VW). 
CAD accounted for 13 cases. No patient (YW or VU) received an implantable defibrilla- 
tor. 
Conclusions: In women age 20-34 years, there was an unexpectedly high rate of unex- 
plained SCD compared to man (56% vs 36%; peO.05). A prospective, population-based 
evaluation of SCD in this age group is warranted. 
1016-11 Antecedent Hypertension Predisposes to Arrhythmic 
Death After Acute Myocardial Infarction: An Insight 
From Contemporary Survival Studies 
Yee Guan Yap, Trinh Duong. Martin Bland, Christian Tarp-Pederson, Lars Kober, Marek 
Malik, Stuart Connolly, Bradley Marchant, A. John Camm, St. George’s Hospital Medical 
School, London, United Kingdom 
Background: Arrhythmic death (AD) is the commonest mode of death after acute myo- 
cardial infarction (AMI) but the role of antecedent hypertension (AH) on the risk of 
arrhythmic death after AMI is unknown. Methods: We pooled the individual data on 3105 
placebo patient (247lM, median age: 65 (23-92)) from E.M.I.A.T.. C.A.M.I.A.T., 
S.W.O.R.D., T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. with LVEF<40% or frequent ventricular 
ectopics. Survival was measured from day 45 after Ml to allow for different recruitment 
periods. Cox multiple regression was used. Results: There were 466 deaths by 2 years 
(220 AD & 172 non-arrhythmic cardiac death (NAD)). After adjusted for significant vari- 
ables associated with either AD or NAD (age, previous MI. gender, angina, systolic blood 
pressure, heart rate, NYHA class, LVEF & Q-wave). patients with AH had a significantly 
higher ratio of AD to NAD at 2 years after the index infarct, but not in patients without AH. 
Cause-specific P-year incidence (AD:NAD, %): AH= 11 .O : 6.4: no AH= 7.7 : 7.2. Ratio of 
relative hazard of AD:NAD (95% Cl): AH= 1.65 (1.02-2.65); no AH=l, p= 0.04. The inter- 
action between AH and AD versus NAD is even greater when measuring from the time of 
index infarct in T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. patients only (p= 0.006). Conclu- 
sion: Our study provides the first data that AH predisposes to AD at 24 months after 
AMI. Such data is vital in refining the risk stratification of high risk patients similar to those 
of MADIT II patients for expensive implantable defibrillator therapy 
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Background: The US Centers for Disease Control and Prevention recently reported a dis- 
proporiionate increase in sudden cardiac death (SCD) in the youngest US women YS 
man (32% vs 10%; age group 15-34 y) during 1969-1996. 
Methods: Due to under-representation of this age group in existing autopsy series, we 
explored the etiologies of SCD in US women (VW) and men (YM) age 20-34 yrs from a 
13-year (1964.1996) autopsy series of SCD. All consecutive cases of SCD referred to 
the JE Edwards Registry from a US 3-county area ware analyzed. Autopsy reports were 
examined, archived hearts subjected to detailed gross/histologic examination and corra- 
lation made with clinical history, toxicologic screen 8 circumstances of death. 
Results: Of 270 total cases (age X20 yrs), YW constituted 14% (n=39). A definitive cause 
of SCD could not be determined in 22 (56%). Findings in other patients included myo- 
carditis (n=4), arrhythmogenic right ventricular dysplasia (n=3), congenital heart disease 
(n=2). coronary artery disease (CAD, n=2), and coronary artery anomalies (n=2). In YM 
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Background: Dynamic atrial overdrive at a rate slightly above the intrinsic rate may sup- 
press recurrences of atrial tachyarrhythmia (AT) in pacemaker patients (pts). We evalu- 
ated clinical efficacy of the DDD+ overdrive mode in dual chamber Inos2 CLS 
pacemakers (Biotronik, Germany). 
Methods: 100 pts with paroxysmal AT and conventional pacing indications (71% sinus 
node disease, 25% atrioventricular block) were randomized to DDD+ or DDD mode at 3 
months after pacemaker implantation. A bipolar atrial lead was placed in the right 
appendage (60%) or laterally (40%). The basic rate was programmed to 61.5 r 4.3 
beatslmin (bpm). Upon sensing an atrial event, the DDD+ mode increased the pacing 
rate by 6 + 2 bpm. followed by 1 bpm rate decrease after each 20 * 3 atrial beats. The 
modes were crossed 6 months after randomization, and the pts were followed for 6 
months in the other mode. The cumulative duration of sustained (> 60 s) AT episodes 
was extracted from the pacemaker memory and compared for the two modes on intrapa- 
tient basis (paired two-tailed t-test). The comparison was made for the entire study popu- 
lation and for different subgroups of pts, in order to evaluate clinical predictors of the 
overdrive therapy outcome. 
Results: Crossover data ware collected in 75 pts; the remaining 25 pts were drop-outs. 
The AT burden was reduced by 26%, from 16.3 (DDD) to 12.0 hours/week (DDD+, p = 
0.066). In 32 pts with AT burden >2% of time (30 miniday), the reduction was 26%, from 
37.6 (DDD) to 27.0 h/week (DDD+, p = 0.044). The subgroups of pts with the most signif- 
icant reduction in AT burden were: 50 pts with < 60% of atrial pacing in DDD mode: 16.1 
(DDD) vs 6.6 h/week (DDD+, 45% reduction, p = 0.016), 25 pts with the basic rate sat to 
65-75 bpm: 29.0 (DDD) vs 16.6 h/week (DDD+, 43% reduction, p = O.Oll), and 34 pts 
who did not take beta-blocker drugs: 16.0 (DDD) vs 7.1 h/week (DDD+, 55% reduction, p 
= 0.026). In the complementary groups to these 3 subgroups there was no additional 
benefit of DDD+ over DDD pacing (O-l 1% reduction in AT burden, p > 0.57). 
Conclusion: DDD+ overdrive pacing exerted the strongest antiarrhythmic effect in pts 
paced less than 60% of time in the DDD mode, in pts with basic rate set to 65-75 bpm, 
and in pts taking no beta-blocker drugs. 
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Background. Preventive atrial pacing may reduce the incidence of atrial fibrillation (AF). 
either by eliminating the triggers and/or by modifying the substrate of the arrhythmia, but 
convincing results about prevention pacing impact from randomized and controlled stud- 
ies are still missing. 
Aim. A prospective, randomized multicentric study has been designed to measure prs- 
vention algorithms impact on AF burden, AF frequency and new endpoints, based on the 
number of sinus rhythm (SR) and AF days, in patients suffering from the brady-tachy 
foml of sick sinus syndrome. 
Methods.108 patients (age 72.3e2.7 years; 52.6% male) from 15 centers wars implanted 
with a DDDRP pacing system (Model AT500, Medtronic, Inc.) including three prevention 
pacing algorithms (Prev). Patients were randomized one-month post implant to DDDR or 
DDDR+Prev for 3 months and then crossed over for additional 3 months. 
Results, by using pacemaker diagnostics, were as follows: 
